Novo Nordisk's pricing approaches while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of cost gouging, declaring the stark contrast in between U.S. selling prices and those in Europe and copyright.The manufacturer states that good use of copyright, in conjunction with diet and work out,